Volpara Health Technologies Limited
Volpara Solutions is committed to helping save families from cancer (ASX: VHT). Volpara’s advanced technology platform combines with the healthcare provider’s expertise to provide a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to when they obtain key results, our platform collects and analyzes information to better understand a patient’s breast cancer risk, while also objectively evaluating image quality and workflow opportunities. These capabilities are being extended to lung cancer screening.
Volpara’s platform is supported by numerous patents, trademarks, and regulatory clearances, including FDA clearance and CE marking, and validated by a volume of peer-reviewed publications unrivalled in the breast screening industry.